Research Library
Discover insights from thousands of peer-reviewed papers on microbial electrochemical systems
Discover insights from thousands of peer-reviewed papers on microbial electrochemical systems
[object Object], [object Object], [object Object] et al.
Environmental Science and Ecotechnology • 2024
[object Object], [object Object], [object Object]
AIP conference proceedings • 2021
[object Object], [object Object], [object Object] et al.
Communications in computer and information science • 2024
[object Object], [object Object], [object Object] et al.
Cambridge University Press eBooks • 2006
[object Object], [object Object], [object Object] et al.
World Wide Journals • 2019
[object Object]
Egyptian Journal of Aquatic Biology and Fisheries • 2024
[object Object], [object Object], [object Object] et al.
Journal of Physics D: Applied Physics • 2025
[object Object], [object Object], [object Object] et al.
GeoPlanet: Earth and Planetary Sciences • 2015
[object Object], [object Object], [object Object]
Microbial Fuel Cell • 2018
[object Object], [object Object], [object Object]
Food Science and Applied Biotechnology • 2018
[object Object], [object Object], [object Object] et al.
Revista Virtual de Química • 2019
[object Object], [object Object], [object Object] et al.
Energy • 2013
[object Object]
Microbial Cell Factories • 2014
Oligosaccharides containing a terminal Gal-alpha1,3-Gal moiety are collectively known as alpha-Gal epitopes. alpha-Gal epitopes are integral components of several medical treatments under development, including flu and HIV vaccines as well as cancer treatments. The difficulty associated with synthesizing the alpha-Gal epitope hinders the development and application of these treatments due to the limited availability and high cost of the alpha-Gal epitope. This work illustrates the development of a whole-cell biocatalyst for synthesizing the alpha-Gal epitope, Gal-alpha1,3-Lac.
[object Object]
Mathematical and computational chemistry • 2002
[object Object], [object Object], [object Object] et al.
2019 Conference on Cognitive Computational Neuroscience • 2018
In recent years bacterial inclusion bodies (IBs) were recognised as highly pure deposits of active proteins inside bacterial cells. Such active nanoparticles are very interesting for further downstream protein isolation, as well as for many other applications in nanomedicine, cosmetic, chemical and pharmaceutical industry.To prepare large quantities of a high quality product, the whole bioprocess has to be optimised. This includes not only the cultivation of the bacterial culture, but also the isolation step itself, which can be of critical importance for the production process.To determine the most appropriate method for the isolation of biologically active nanoparticles, three methods for bacterial cell disruption were analyzed.
• 0
Institute of Research and Community Services Diponegoro University (LPPM UNDIP) • 2025
[object Object]
Fourth Genre Explorations in Nonfiction • 2010
JRSKT - Jurnal Riset Sains dan Kimia Terapan • 2017
[object Object], [object Object], [object Object] et al.
International Journal of Sports Medicine • 2012
[object Object], [object Object], [object Object] et al.
Applied Catalysis A General • 2020
[object Object], [object Object]
Research Square • 2020
[object Object]
Water Science & Technology • 2007
[object Object], [object Object], [object Object] et al.
Techno Com • 2023
[object Object], [object Object]
Universitas Islam Bandung (Unisba) • 2023